ATNM
Actinium Pharmaceuticals, Inc.
-0.02 (-1.60%)1.22USD26.9K成交股數38.4M市值3.5本益比(近四季)1.1股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 35.0M | – | – | 90K | – | – | – | – | 927K | −2.0M | 1.1M | 461K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.4M | 4.2M | 4.3M | 4.2M | 4.9M | 7.7M | 9.8M | 8.8M | 6.6M | 8.1M | 11.6M | 11.1M |
| 銷售管理費用 | 2.1M | 1.7M | 2.1M | 1.5M | 2.6M | 8.9M | 2.8M | 3.6M | 3.0M | 2.3M | 2.7M | 4.6M |
| 營業利益 | 27.6M-467% | −5.9M-65% | −6.4M-49% | −5.7M-54% | −7.5M-22% | −16.6M+61% | −12.6M-12% | −12.4M-21% | −9.6M | −10.3M | −14.4M | −15.6M |
| 營業利益率 | 78.8% | – | – | -6,324.4% | – | – | – | – | -1,035.3% | 516.6% | -1,335.0% | -3,393.1% |
| 稅後淨利 | 27.9M-506% | −5.5M-65% | −5.9M-49% | −5.1M-55% | −6.9M-21% | −15.9M+71% | −11.6M-13% | −11.4M-25% | −8.7M | −9.3M | −13.3M | −15.2M |
| 淨利率 | 79.7% | – | – | -5,701.1% | – | – | – | – | -935.3% | 465.7% | -1,235.0% | -3,293.1% |
| 稀釋 EPS | 0.89-505% | -0.18-65% | -0.20-46% | -0.16-58% | -0.22-29% | -0.51+55% | -0.37-24% | -0.38-34% | -0.31 | -0.33 | -0.49 | -0.58 |
| 稀釋股數 | 31.4M | 31.2M | 31.2M | 31.2M | 31.2M | 31.2M | 31.1M | 30.1M | 27.9M | 26.6M | 27.1M | 26.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 36.5M | 42.1M | 48.0M | 53.4M | 59.9M | 65.3M | 78.7M | 86.0M | 84.1M | 76.7M | 83.0M | 91.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 40.2M | 45.4M | 51.8M | 56.2M | 63.0M | 68.6M | 82.1M | 89.9M | 88.4M | 81.4M | 88.9M | 99.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.9M | 43.1M | 43.9M | 42.4M | 44.0M | 43.0M | 43.9M | 46.0M | 44.5M | 45.1M | 45.4M | 46.0M |
| 股東權益 | 30.3M | 2.3M | 7.8M | 13.8M | 19.0M | 25.7M | 38.2M | 43.8M | 43.9M | 36.4M | 43.6M | 53.1M |
| 負債比 | 24.5% | 94.9% | 84.9% | 75.5% | 69.8% | 62.6% | 53.5% | 51.2% | 50.4% | 55.3% | 51.0% | 46.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.9M-22% | – | – | – | −7.6M | – | – | −7.4M | – | – | – |
| 資本支出 | – | 2K | – | – | – | – | – | – | 11K | – | – | – |
| 自由現金流 | – | −5.9M | – | – | – | – | – | – | −7.4M | – | – | – |
| 折舊攤銷 | – | 29K | – | – | – | 47K | – | – | 216K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -796.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 90K
| Other Revenue | 90K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 90K | – | −33.9M | -37,652.2% | -1.09 | −24.7M |
| FY2024 | – | – | −38.2M | –% | -1.27 | −33.1M |
| FY2023 | 81K | -92.1% | −48.8M | -60,269.1% | -1.83 | −47.5M |
| FY2022 | 1.0M | -10.0% | −33.0M | -3,205.5% | -1.37 | 8.3M |
| FY2021 | 1.1M | +542.7% | −24.8M | -2,165.6% | -1.20 | −21.0M |
| FY2020 | 178K | +3.5% | −22.2M | -12,480.3% | -1.83 | −21.9M |
| FY2019 | 172K | -0.8% | −21.9M | -12,732.6% | -4.40 | −21.5M |
| FY2018 | 173K | – | −23.7M | -13,644.5% | -0.22 | −20.7M |